City

Paris (1)

Condition

Systemic Wegener's Granulomatosis (1)

Overall Status

Unknown status (1)

Sign in for free

Phase

phase 3 (1)

Sponsor

Hospices Civils de Lyon (1)

Collaborator

Intervention

azathioprine: 2 mg/kg/day (1)

methotrexate 0.3 mg/kg/week, to a maximum and optimal dose of 25 mg/week (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Other (1)

Study Type

Interventional (1)

systemic wegener's granulomatosis

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Systemic Wegener's Granulomatosis Trial in Paris (Azathioprine: 2 mg/kg/day, methotrexate 0.3 mg/kg/week, to a maximum and

Unknown status

Systemic Wegener's Granulomatosis

Azathioprine: 2 mg/kg/day
methotrexate 0.3 mg/kg/week, to a maximum and optimal dose of 25 mg/week

Paris, France

Christian PAGNOUX

Oct 9, 2007